Odyssey Health (ODYY) EBIT (QoQ) (2015 - 2026)
Odyssey Health (ODYY) EBIT (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -63.54% |
| Jan 31, 2026 | 39.99% |
| Oct 31, 2025 | -94.75% |
| Jul 31, 2025 | -20.63% |
| Apr 30, 2025 | 17.59% |
| Jan 31, 2025 | 72.97% |
| Oct 31, 2024 | -344.04% |
| Jul 31, 2024 | 163.76% |
| Apr 30, 2024 | 67.83% |
| Jan 31, 2024 | -233.32% |
| Oct 31, 2023 | 47.00% |
| Jul 31, 2023 | 40.15% |
| Apr 30, 2023 | 26.36% |
| Jan 31, 2023 | 28.46% |
| Oct 31, 2022 | -13.25% |
| Jul 31, 2022 | 36.00% |
| Apr 30, 2022 | -45.07% |
| Jan 31, 2022 | -38.24% |
| Oct 31, 2021 | 45.18% |
| Jul 31, 2021 | 78.44% |